Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Feihu Xie"'
Autor:
Chen Liang, Zhaoqian He, Qiang Tao, Xiang Tang, Lingmin Jiang, Xinyue Tu, Zonghao Liu, Hua Chen, Feihu Xie, Yun Zheng
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 24, p 7665 (2023)
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China, accounting for the majority of primary liver cancer cases. Liver resection is the preferred curative method for early-stage HCC. However, up to 80–85% of patients h
Externí odkaz:
https://doaj.org/article/707a537a1b9c4aa5b098377d0814cf58
Autor:
Lejia Sun, Huayu Yang, Yanan Wang, Xinyu Zhang, Bao Jin, Feihu Xie, Yukai Jin, Yuan Pang, Haitao Zhao, Xin Lu, Xinting Sang, Hongbing Zhang, Feng Lin, Wei Sun, Pengyu Huang, Yilei Mao
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The existing in vitro models for antitumor drug screening have great limitations. Many compounds that inhibit 2D cultured cells do not exhibit the same pharmacological effects in vivo, thereby wasting human and material resources as well as time duri
Externí odkaz:
https://doaj.org/article/9aae58771e5f45fc948b43b48d1f42fe
Autor:
Gang Xu, Lejia Sun, Yunzhu Li, Feihu Xie, Xiaoxiang Zhou, Huayu Yang, Shunda Du, Haifeng Xu, Yilei Mao
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Recently, blockade of immune checkpoint has emerged as one of the most potential treatments for solid tumors. Programmed cell death ligand 1(PD-L1), a member of the B7 family of molecules, plays a crucial role in tumor immunobiology. Howe
Externí odkaz:
https://doaj.org/article/1ef21613847349ad938e48d02920d2c3
Publikováno v:
RSC Advances; 2024, Vol. 14 Issue 14, p9547-9558, 12p
Autor:
Yangyang Yan, Shaowen Cheng, Ping Zhou, Heying Li, Xiaoran Liu, Manping Lin, Feihu Xie, Keke Zhang, Yi Zhang, Chenyang Zhang, Shuang Zhao, Jiahua Shi, Jinghua Li
Publikováno v:
Nanoscale advances. 4(13)
Pt atom mediates electrooxidation to generate H2O2, causing a series of Fenton reactions triggered by Cu atom, for further elimination of dyestuff pollutions. The electrocatalytic process provides an acidic pH in solution, a suitable pH range for Fen
Autor:
Xinyue, Tu, Jing, Yang, Yingbin, Zheng, Chen, Liang, Qiang, Tao, Xiang, Tang, Zonghao, Liu, Lingmin, Jiang, Zhaoqian, He, Feihu, Xie, Yun, Zheng
Publikováno v:
International Immunopharmacology. 113:109401
To compare the efficacy and safety of immunotherapy plus regorafenib versus regorafenib only in patients with pretreated hepatocellular carcinoma (HCC).Immunotherapy plus regorafenib or regorafenib alone was analyzed in patients with advanced HCC wit
Publikováno v:
Hepatobiliary Surg Nutr
Autor:
Xin Lu, Feihu Xie, Gang Xu, Bao Jin, Wei-Yu Xu, Shunda Du, Lejia Sun, Huanhuan Yin, Haifeng Xu, Ai Guan, Yilei Mao, Yiyao Xu, Haitao Zhao, Meixi Liu, Xinting Sang, Huayu Yang
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND Gallbladder carcinoma (GBC) carries a poor prognosis and requires a prediction method. Gamma-glutamyl transferase–to–platelet ratio (GPR) is a recently reported cancer prognostic factor. Although the mechanism for the relationship betw
Autor:
Huanhuan Yin, Lejia Sun, Yilei Mao, Junying Zhou, Qing Wang, Bao Jin, Dongyue Wang, Feihu Xie, Yukai Jin, Meixi Liu, Huayu Yang, Gang Xu
Publikováno v:
Endocrine. 69(2)
Indicators to assess early liver damage and disease progression in nonalcoholic fatty liver disease (NAFLD) remain unsatisfactory. Albumin binding function has been reported to be an early indicator of liver damage in hepatitis and liver cirrhosis. H
Autor:
Shi Feng, Shouxian Zhong, Huayu Yang, Haifeng Xu, Yanan Wang, Hongbing Zhang, Yiyao Xu, Haitao Zhao, Xin Lu, Xinting Sang, Feihu Xie, Xin Wang, Pengyu Huang, Gang Xu, Lejia Sun, Wei Sun, Yilei Mao, Shunda Du, Bao Jin
Publikováno v:
SSRN Electronic Journal.
Background: Hepatocellular carcinoma (HCC) is the most common liver cancer and the second most lethal tumor worldwide. Although the treatment strategies are improved constantly, overall 5-years’ survival rates still remain devastating. One of the m